Upcoming Talks Why perpetual KYC and quality data are good for compliance Mastering 505(b)(2) Drug Development:Strategic Pillars & Bridging Considerations Mastering 505(b)(2) Drug Development:Strategic Pillars & Bridging Considerations Ruggedness and Robustness in Nitrosamine Analysis from Pharmaceutical Elastomers Endotoxin Detection Challenges Associated With The Development Of A Novel VLP Insights into Practical Issues Associated with Extractables Testing... On Demand Talks Managing compliance and change in a time of global uncertainty 2023 Mid-Year Fiduciary Update for Defined Contribution Plan Sponsors Aligning Application Security & Compliance IND-Enabling Nonclinical Studies: Are You Prepared? Roundtable: Keeping Pace with Changing Regulations What To Expect For Your CMMC 2.0 Level 2 Audit EU's Energy Efficiency Directive: its implications for the EU and beyond Navigating the EU MDR as a Medical Device Manufacturer Positioning GRC as an Enabler with Integrated Data Bridging the gap between regulatory FDA compliance and modern software delivery Explore all talks
